India Glycols Limited (INDIAGLYCO) AI Stock Analysis

• Market Cap: ₹63.88B
• Dividend Yield: 0.47%
• Average Volume (3M): 19.23K
• Price to Earnings (P/E): 22.8
• Beta (1Y): 1.75
• Revenue Growth: 5.61%
• EPS Growth: 33.63%
• Country: IN
• Employees: 1,326
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): 10.25
• Shares Outstanding: 67,026,764
• 10 Day Avg. Volume: 24,007
• 30 Day Avg. Volume: 19,229
• PEG Ratio: 0.23
• Price to Book (P/B): 0.79
• Price to Sales (P/S): 0.47
• P/FCF Ratio: -4.48
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 65 Neutral
• Price Target: ₹1,183.00 ▲(17.40% Upside)

India Glycols Limited's stock score is driven by strong technical momentum, despite financial challenges such as declining margins and high leverage. The valuation suggests potential overvaluation, and the low dividend yield limits income appeal. The absence of earnings call and corporate events data means these factors do not influence the score.

Positive Factors

Revenue Growth

Despite a slowdown, the company maintains strong revenue growth, indicating robust demand for its products and potential for market expansion.

Product Diversification

Diverse product offerings across multiple industries reduce dependency on a single market, enhancing resilience against sector-specific downturns.

Sustainable Practices

Commitment to sustainability and bio-based products positions the company favorably in a market increasingly focused on environmental responsibility.

Negative Factors

Declining Profit Margins

Decreasing profit margins suggest challenges in cost management or pricing power, potentially impacting long-term profitability.

Rising Debt Levels

Increased leverage could heighten financial risk, limiting the company's ability to invest in growth opportunities and manage economic downturns.

Negative Free Cash Flow

Negative free cash flow indicates potential liquidity constraints, which could affect the company's ability to fund operations and growth initiatives.

India Glycols Limited Business Overview & Revenue Model

Company Description

India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. The company operates through Industrial Chemical, Ethyl Alcohol, and Nutraceuticals segments. It offers monoethylene, diethylene, and triethylene glycols; polyethylene glycols; fatty alcohol, acid, and amine ethoxylates; alkyl phenol ethoxylates; castor/natural oil ethoxylates; and ethoxylated and propoxylated co-polymers. The company also provides polysorbates; glycol ethers and acetates; brake fluids and anti-freeze coolants; performance chemicals; natural gums, including guar gums and other hydrocolloid products; extra neutral alcohols/rectified spirits; Indian-made foreign liquor; and alcohol-based hand sanitizers. In addition, it offers natural active pharmaceutical ingredients, standardized botanical and herbal extracts, and spice extracts; and industrial gases, such as liquid oxygen, argon, nitrogen, and carbon dioxide, as well as IGL Steri-gas ethylene oxide and carbon dioxide gas mixtures. The company also exports its products. It serves agrochemical, automotive, detergent, healthcare and food processing, mining, oil and gas, paper, personal care, pharmaceutical, paint and emulsion polymerization, textile, and other industries. The company was formerly known as UP Glycols Limited and changed its name to India Glycols Limited in August 1986. India Glycols Limited was incorporated in 1983 and is headquartered in Noida, India.

How the Company Makes Money

India Glycols Limited generates revenue through multiple streams, primarily by manufacturing and selling a wide array of chemical products. The company's key revenue streams include the production of ethylene glycol, which is used in antifreeze and as a precursor for polyester fibers, and other glycol derivatives used in different industrial applications. INDIAGLYCO also earns income from specialty chemicals that serve niche markets, such as personal care and pharmaceuticals. Additionally, the firm has established partnerships and collaborations with various domestic and international companies, enhancing its market presence and product offerings. The company's focus on sustainable practices and the development of bio-based products further contributes to its earnings by aligning with the growing demand for environmentally friendly solutions.

India Glycols Limited Financial Statement Overview

Summary

India Glycols Limited exhibits a mixed financial picture. Strong revenue growth and effective equity utilization are positive signs. However, declining profit margins, increased leverage, and negative free cash flow highlight areas of concern. The company must focus on enhancing profitability and managing debt to ensure sustainable financial health and mitigate potential risks.

Income Statement

India Glycols Limited shows a mixed performance in its income statement. The gross profit margin is healthy at approximately 26.5% for 2025, indicating efficient cost management. However, the net profit margin saw a decline from 5.3% in 2024 to 6.1% in 2025, showing moderate profitability. Revenue growth was strong in 2024 at 23.3%, but slowed down to 15.3% in 2025. EBIT margin is at 6.5% for 2025, indicating some operational efficiency but room for improvement. Overall, while there are areas of strength, such as revenue growth, declining margins present a challenge.

Balance Sheet

The balance sheet reveals a stable yet cautious financial position. The debt-to-equity ratio increased to 0.84 in 2025, suggesting higher leverage which could heighten financial risk. Return on Equity (ROE) improved to 10.2%, reflecting better utilization of equity. The equity ratio is stable at 36.5%, indicating a reasonable proportion of assets financed by equity. While the company maintains a solid equity base, increasing debt levels pose a potential risk to financial stability.

Cash Flow

Cash flow analysis indicates some challenges, particularly in free cash flow generation which remained negative at -3.98 billion in 2025. The operating cash flow to net income ratio stands at 1.57, which is healthy, suggesting good cash conversion from profits. However, the free cash flow to net income ratio is negative due to high capital expenditures, indicating potential future cash flow constraints. Improving free cash flow generation should be a priority to bolster financial flexibility.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	38.40B	37.68B	32.94B	26.37B	28.68B	22.92B
Gross Profit	11.68B	9.99B	10.55B	10.69B	8.45B	7.06B
EBITDA	5.86B	5.11B	4.28B	3.47B	4.98B	2.86B
Net Income	2.44B	2.31B	1.73B	1.25B	3.40B	1.32B
Balance Sheet
Total Assets	0.00	61.76B	56.17B	48.58B	46.31B	41.19B
Cash, Cash Equivalents and Short-Term Investments	774.40M	546.92M	746.42M	2.83B	430.66M	396.11M
Total Debt	0.00	18.92B	13.48B	11.12B	10.42B	11.37B
Total Liabilities	-22.56B	39.20B	35.66B	29.57B	28.58B	29.51B
Stockholders Equity	22.56B	22.56B	20.51B	19.01B	17.92B	11.69B
Cash Flow
Free Cash Flow	0.00	-3.98B	-1.14B	-1.13B	-2.64B	-115.54M
Operating Cash Flow	0.00	3.62B	4.39B	3.26B	1.16B	1.37B
Investing Cash Flow	0.00	-7.36B	-5.03B	-3.30B	764.47M	-1.48B
Financing Cash Flow	0.00	3.54B	899.12M	-5.10M	-1.89B	107.45M

India Glycols Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1007.65
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDIAGLYCO, the sentiment is Negative. The current price of 1007.65 is below the 20-day moving average (MA) of 1041.86, below the 50-day MA of 1046.46, and above the 200-day MA of 894.44, indicating a neutral trend. The MACD of -13.26 indicates Positive momentum. The RSI at 39.11 is Neutral, neither overbought nor oversold. The STOCH value of 21.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:INDIAGLYCO.

India Glycols Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GNFC	70 Outperform	₹70.48B	11.08	―	3.68%	-7.53%	42.74%
INDIAGLYCO	65 Neutral	₹63.88B	22.77	―	0.47%	5.61%	33.63%
SUNFLAG	62 Neutral	₹45.06B	22.36	―	0.28%	6.44%	36.54%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
GUJALKALI	59 Neutral	₹35.11B	23,436.27	―	3.11%	10.35%	―
LXCHEM	51 Neutral	₹42.07B	50.38	―	0.29%	-2.93%	-37.94%
CAMLINFINE	46 Neutral	₹29.41B	-97.11	―	―	9.21%	87.89%

India Glycols Limited Corporate Events

India Glycols Announces Trading Window Closure Ahead of Financial Results Meeting

India Glycols Limited has announced the closure of its trading window in compliance with SEBI regulations, ahead of its Board of Directors meeting scheduled for November 14, 2025. The meeting will consider and approve the company’s unaudited financial results for the quarter and half-year ending September 30, 2025. This announcement is part of the company’s commitment to regulatory compliance and transparency, potentially impacting investor relations and market perceptions.